Physician profile
Rahul Kar
NPI 1518353432
$6,922.80
in general payments reported to CMS, 2019-2025
38 companies · $1,200 in 2025
The $1,200 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $220 · 2021: $180 · 2022: $1,381 · 2023: $1,179 · 2024: $2,762 · 2025: $1,200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,655 · Travel and Lodging: $486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,654.89 |
| Travel and Lodging | $485.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $1,809.38 | 2024-2025 | Trivex System, Restoreflow |
| Medtronic, INC. | $1,206.47 | 2021-2025 | Endurant Iis, Venaseal |
| Silk Road Medical, INC. | $884.81 | 2022 | |
| Philips North America LLC | $827.17 | 2022-2025 | (P84) Igt Devices Systems, IV Other, Intrasight Mobile |
| Inari Medical, INC. | $582.12 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic Vascular, INC. | $220.46 | 2020 | |
| Cook Medical LLC | $123.90 | 2022 | |
| Endologix LLC | $119.09 | 2024 | |
| Terumo Medical Corporation | $109.59 | 2022-2023 | Angio-Seal |
| Cagent Vascular INC | $96.00 | 2024 | Serrantor |
| Novo Nordisk INC | $89.91 | 2024-2025 | Wegovy |
| Cosa Medical, LLC | $83.80 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $53.79 | 2023-2024 | Uptravi, Opsumit |
| Abiomed | $51.95 | 2025 | |
| Boston Scientific Corporation | $50.97 | 2025 | Watchman Flx |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $49.75 | 2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $47.80 | 2022-2024 | Xarelto |
| Abbott Laboratories | $46.73 | 2022-2023 | Diamondback Peripheral |
| Bard Peripheral Vascular, INC. | $42.88 | 2024-2025 | Rotarexs 6 F X 135 Cm |
| Novartis Pharmaceuticals Corporation | $38.39 | 2025 | |
| Bridgebio Pharma, INC. | $34.50 | 2025 | Attruby |
| Amgen INC. | $33.67 | 2024 | Repatha |
| Penumbra, INC. | $28.54 | 2022 | |
| Organogenesis INC. | $27.86 | 2025 | Puraply Wound Matrix |
| Imperative Care, INC | $27.40 | 2025 | Symphony Catheter |
| Thrombolex, INC. | $24.16 | 2025 | Bashir Endovascular Catheter |
| United Therapeutics Corporation | $22.31 | 2024 | Tyvaso |
| Stryker Corporation | $20.88 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.01 | 2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $18.86 | 2024 | Camzyos |
| W. L. Gore & Associates, INC. | $18.29 | 2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Pfizer INC. | $18.24 | 2025 | |
| Solventum Corporation | $18.14 | 2024 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Smith+Nephew, INC. | $16.68 | 2024 | Renasys Touch, Pico 7 |
| Astrazeneca Pharmaceuticals LP | $16.50 | 2024 | Farxiga |
| Reflow Medical INC | $15.57 | 2025 | |
| Cashflow Solutions, LLC | $14.77 | 2023 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Cordis US Corp. | $12.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rahul Kar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.